2022 annual financial data
Cardiff Oncology 2022 Operating margin
Direct answer
Operating margin was -10,337.31%.
Operating income was -39,902,000 USD and net income was -38,704,000 USD.
Operating cash flow was -33,820,000 USD.
Get free Cardiff Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 386,000 USD
- Operating income
- -39,902,000 USD
- Net income
- -38,704,000 USD
- Operating cash flow
- -33,820,000 USD